Suppr超能文献

咪唑(啉)α2-肾上腺素能受体激动剂增强巴比妥酸盐诱导的大鼠额叶皮质突触前去甲肾上腺素能功能改变

Potentiation of barbiturate-induced alterations in presynaptic noradrenergic function in rat frontal cortex by imidazol(in)e alpha2-adrenoceptor agonists.

作者信息

Dalley J W, Parker C A, Wülfert E, Hudson A L, Nutt D J

机构信息

Department of Experimental Psychology, University of Cambridge.

出版信息

Br J Pharmacol. 1998 Oct;125(3):441-6. doi: 10.1038/sj.bjp.0702091.

Abstract
  1. In order to resolve the extent to which presynaptic noradrenergic mechanisms contribute to the anaesthetic-sparing effects of alpha2-adrenoceptor agonists in vivo microdialysis was used to investigate the combined effects of sodium pentobarbitone and imidazol(in)e alpha2-adrenoceptor agonists on extracellular levels of noradrenaline (NA) in the rat frontal cortex. 2. Dialysate levels of NA were markedly reduced by the addition of TTX (2 microM) or by the removal of calcium in the perfusate. These data imply that dialysate NA levels are ultimately dependent on exocytotic release mechanisms from afferent coeruleo-cortical neurones. 3. Systemic administration of sodium pentobarbitone (85 mg kg(-1), i.p.) induced general anaesthesia and reduced NA levels by 92% after 30 min. The restoration of basal levels 90 min later was closely associated with a return of the corneal blink reflex. 4. Basal NA levels in conscious animals were not affected by an intravenous infusion of equally radioactive solutions of either imidazoline (clonidine) or imidazole (mivazerol) alpha2-adrenoceptor agonists. The dose rate employed for each compound was 2 microg kg(-1) h(-1) over 2 h. 5. The co-administration of intravenous clonidine or mivazerol, each at 2 microg kg(-1) h(-1) for 2 h, with sodium pentobarbitone (85 mg kg(-1), i.p.), produced a marked and prolonged reduction in NA efflux. After 2 h, NA levels remained suppressed by 95% (clonidine) and 80% (mivazerol) and animals remained deeply anaesthetized. 6. The accumulation of tritium in brain tissue was 42-73% lower across all brain regions examined after [3H]-mivazerol administration than after [3H]-clonidine administration. Sodium pentobarbitone did not alter the accumulation of tritium in brain tissue after the administration of either alpha2-adrenoceptor agonist. 7. These data demonstrate that alpha2-adrenoceptor agonists potentiate the inhibitory effects of sodium pentobarbitone on extracellular levels of NA in the frontal cortex. Further studies will be necessary to establish a causal role of noradrenergic mechanisms in the potentiation of anaesthesia by selective alpha2-adrenoceptor agonists.
摘要
  1. 为了确定突触前去甲肾上腺素能机制在α2 - 肾上腺素能受体激动剂的麻醉节省效应中所起作用的程度,采用体内微透析技术研究戊巴比妥钠与咪唑啉()类α2 - 肾上腺素能受体激动剂对大鼠额叶皮质细胞外去甲肾上腺素(NA)水平的联合作用。2. 添加TTX(2 microM)或去除灌流液中的钙可使透析液中NA水平显著降低。这些数据表明,透析液中NA水平最终依赖于传入蓝斑 - 皮质神经元的胞吐释放机制。3. 腹腔注射戊巴比妥钠(85 mg kg(-1))可诱导全身麻醉,并在30分钟后使NA水平降低92%。90分钟后基础水平的恢复与角膜反射的恢复密切相关。4. 静脉输注同等放射性的咪唑啉(可乐定)或咪唑(米伐折醇)类α2 - 肾上腺素能受体激动剂溶液,对清醒动物的基础NA水平无影响。每种化合物的给药速率为2 microg kg(-1) h(-1),持续2小时。5. 静脉注射可乐定或米伐折醇,剂量均为2 microg kg(-1) h(-1),持续2小时,与腹腔注射戊巴比妥钠(85 mg kg(-1))联合使用,可使NA流出量显著且持续降低。2小时后,NA水平仍被抑制95%(可乐定)和80%(米伐折醇),动物仍处于深度麻醉状态。6. 给予[3H] - 米伐折醇后,在所有检测的脑区中,脑组织中氚的蓄积量比给予[3H] - 可乐定后低42 - 73%。戊巴比妥钠在给予任何一种α2 - 肾上腺素能受体激动剂后均未改变脑组织中氚的蓄积量。7. 这些数据表明,α2 - 肾上腺素能受体激动剂可增强戊巴比妥钠对额叶皮质细胞外NA水平的抑制作用。有必要进行进一步研究以确定去甲肾上腺素能机制在选择性α2 - 肾上腺素能受体激动剂增强麻醉作用中的因果关系。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验